Lomanowska, Anna M.
Tahir, Rabia
Choo, Christina
Zhu, Sabrina
Wang, Dora Y.
Slepian, P. Maxwell
Katz, Joel
Clarke, Hance
Funding for this research was provided by:
Health Canada's Substance Use and Addictions Program
Article History
Received: 17 June 2024
Accepted: 17 January 2025
First Online: 29 January 2025
Declarations
:
: The activities described in this project were approved by the Quality Improvement Review Committee (QIRC) at the University Health Network (UHN), including protocols and informational consent (QI ID#: 21–0310). QIRC determined that the project falls outside the scope of research requiring Research Ethics Board (REB) review, as described in the Canadian Tri‐Council Policy Statement V.2. This determination was subsequently reviewed and confirmed by a UHN REB Chair.The need for signed consent to participate was deemed unnecessary as part of the approval by QIRC (QI ID#: 21–0310) and in accordance with Canadian Tri‐Council Policy Statement V.2. An informational consent letter was provided instead to all participants, which outlined the objective of the project, privacy and confidentiality, and contact information for the project team and QIRC.
: Not applicable.
: The authors declare no competing interests.